The market performance of Roivant Sciences Ltd has been somewhat stable. Over the past year, the company’s stock achieved a high of $13.24 on 09/28/23, with the lowest value for the same timeframe being $7.01, recorded on 04/14/23.
52-week price history of ROIV Stock
Analyzing the 52-week price history of a stock, including its high and low prices, can provide valuable insight into its current status and potential future performance. Roivant Sciences Ltd’s current trading price is -13.82% away from its 52-week high, while its distance from the 52-week low is 62.77%. The stock’s price range for this period has remained between $7.01 and $13.24. The Healthcare sector company’s shares managed to surpass a trading volume of around 6.69 million for the day, which was noticeably lower compared to the shares’ average daily volume of 7.35 million over the last three months.
Financial Performance and Market Capitalization
Roivant Sciences Ltd (ROIV) has experienced a quarterly decline of -0.26% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 9.19B and boasts a workforce of 904 employees.
Moving average and trading volume data
Based on Barchart.com data, the company’s moving average over the 100-day period was 10.57, with a change in price of +2.36. Similarly, Roivant Sciences Ltd recorded 6,600,267 in trading volume during the last 100 days, posting a change of +26.08%.
ROIV Debt-to-equity ratio analysis
The debt-to-equity (D/E) ratio is a valuable metric that offers insight into a company’s financial health and standing in the market. This ratio is calculated by dividing a company’s current total liabilities by its shareholders’ equity. The D/E ratio illustrates the extent of debt a company is utilizing to support its assets in relation to the value of its shareholders’ equity. At the time of writing, the total D/E ratio for ROIV stands at 0.08. Similarly, the long-term debt-to-equity ratio is also 0.07.
ROIV Stock Stochastic Average
As of today, the raw stochastic average of Roivant Sciences Ltd over the past 50 days is 74.46%. This is a decrease compared to the raw stochastic average of the last 20 days, which was recorded at 80.88%. Additionally, the Stochastic %K and %D values for the company were 90.19% and 91.71%, respectively, over the past 20 days.
ROIV Stock Price Performance Analysis
The performance of the stock price over the year has been up and down, leaving investors with either an optimistic or pessimistic outlook, depending on how they interpret the data. This year’s metric has recorded a Price increase of 1.60%. However, over the past six months, we’ve seen a weaker performance of 5.65%. The price of ROIV fallen by 6.84% over the last 30 days. And in the last five days, it has surged by 4.49%.
